https://www.marketscreener.com/quote/stock/AIM-IMMUNOTECH-INC-65218228/news/AIM-ImmunoTech-Inc-Announces-Encouraging-Translational-Data-from-Phase-2-Study-Evaluating-Ampligen-45275828/?utm_source=telegram&utm_medium=social&utm_campaign=share